Fowl Cholera (Avian Cholera): Etiology, Epidemiology, Clinical Signs, Pathology, Diagnostics, Treatment, and Zoonotic Potential
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Fowl cholera is caused by the Gram-negative bacterium Pasteurella multocida, with capsular serogroup A being the most prevalent in avian hosts, and its virulence is multifactorial, involving a polysaccharide capsule and lipopolysaccharide (LPS).
- Transmission occurs horizontally via respiratory aerosols and ingestion of contaminated feed or water, with carrier birds acting as a primary reservoir, and risk factors include high stocking density, poor ventilation, and concurrent infections.
- Clinical signs range from peracute sudden death to acute fever, depression, and diarrhea, and chronic localized infections such as wattle edema, conjunctivitis, and arthritis.
- Definitive diagnosis relies on isolation and identification of P. multocida through culture and biochemical tests, supported by molecular methods like PCR targeting the kmt1 gene and serological assays such as ELISA for antibody detection.
- Treatment involves early antimicrobial administration via feed or water, with common drugs including tetracyclines and sulfonamides, but antimicrobial resistance is a growing concern, necessitating susceptibility testing.
- Control strategies focus on strict biosecurity measures and vaccination using bacterins, live attenuated vaccines, or next-generation recombinant and subunit vaccines, while eradication is challenging due to carrier birds.
Etiology
Fowl cholera, also known as avian cholera, is a highly contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. The question "fowl cholera is caused by which bacteria" is answered definitively: P. multocida is the sole etiologic agent. This Gram-negative, non-motile, encapsulated coccobacillus is a member of the family Pasteurellaceae [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The organism exhibits considerable antigenic and genetic diversity, classified by capsular serogroups (A, B, D, E, F) and lipopolysaccharide (LPS) genotypes [<a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. In avian hosts, capsular serogroup A is overwhelmingly the most prevalent, although serogroups D and F are also reported in poultry and wild birds [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>, <a href="#ref-8">8</a>].
The virulence of P. multocida is multifactorial, involving a polysaccharide capsule, LPS, outer membrane proteins (OMPs), filamentous hemagglutinins (FhaB), and a potent protein toxin (PMT) [<a href="#ref-9">9</a>, <a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. The hyaluronic acid capsule is a critical anti-phagocytic factor, and its production is regulated by the stringent response [<a href="#ref-12">12</a>]. The LPS outer core undergoes phase variation, contributing to immune evasion and adaptation to different host environments [<a href="#ref-7">7</a>]. The PMT toxin, a 146 kDa mitogenic protein, activates intracellular signaling cascades (Gq, G12/13, G1), leading to cellular proliferation and osteoclast activation, though its direct role in avian disease pathogenesis remains under investigation [<a href="#ref-11">11</a>]. Filamentous hemagglutinin B1 (FhaB1) has been shown not to be required for pathogenesis in turkey poults, indicating that other adhesins are functionally redundant [<a href="#ref-9">9</a>]. The gene hyaD (hyaluronan synthase) contributes to capsule assembly and is positively correlated with virulence [<a href="#ref-10">10</a>].
Epidemiology
Host Range and Geographic Distribution
Fowl cholera affects a broad spectrum of avian species, including chickens, turkeys, ducks, geese, and numerous wild waterfowl [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>, <a href="#ref-15">15</a>]. Turkeys and waterfowl are particularly susceptible, often experiencing high morbidity and mortality [<a href="#ref-8">8</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. The disease is distributed globally and is considered one of the most significant bacterial diseases of poultry, causing substantial economic losses to the commercial industry [<a href="#ref-1">1</a>, <a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>].
Transmission and Risk Factors
Transmission occurs horizontally via respiratory aerosols, ingestion of contaminated feed or water, and through breaks in the skin or mucous membranes [<a href="#ref-14">14</a>, <a href="#ref-16">16</a>, <a href="#ref-20">20</a>]. Carrier birds, which harbor the organism in their nasopharynx or tonsils without showing clinical signs, serve as a primary reservoir for outbreaks [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>]. Stressors such as high stocking density, poor ventilation, nutritional deficiencies, concurrent infections, and climate changes are well-documented predisposing factors [<a href="#ref-13">13</a>, <a href="#ref-14">14</a>, <a href="#ref-16">16</a>]. A case-case study exploring land cover impacts found that specific environmental features, such as proximity to wetlands and open water, were associated with increased odds of fowl cholera outbreaks [<a href="#ref-14">14</a>]. Coinfections with other pathogens, such as Mycoplasmoides gallisepticum, can exacerbate disease severity and mortality rates [<a href="#ref-13">13</a>]. The term "fowl cholera meaning in bengali" (পোল্ট্রি কলেরা) is used in the Indian subcontinent to describe this same disease entity, which is a significant concern in backyard and commercial poultry systems in regions such as Bangladesh [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>].
Clinical Signs
The clinical presentation of fowl cholera varies with the virulence of the P. multocida strain, the host species, and the route of exposure [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>, <a href="#ref-18">18</a>]. Three primary disease forms are described: peracute, acute, and chronic.
Peracute Form
The peracute form is characterized by sudden death with few premonitory signs. Mortality can reach 100% in susceptible flocks, particularly in slow-growing broiler chickens and turkeys [<a href="#ref-4">4</a>, <a href="#ref-8">8</a>]. Birds are often found dead in good body condition with food in the crop [<a href="#ref-4">4</a>].
Acute Form
The acute form presents with fever (pyrexia), anorexia, depression, ruffled feathers, mucoid or bloody nasal discharge, dyspnea, cyanosis of the comb and wattles, and profuse diarrhea that may contain blood [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>]. Morbidity and mortality rates are typically high, leading to a rapid decline in egg production in layers [<a href="#ref-4">4</a>].
Chronic Form
Chronic fowl cholera manifests as localized infections, including swollen and edematous wattles (wattle edema), conjunctivitis, pharyngeal abscesses, torticollis from otitis media or interna (due to inner ear infection), and lameness from arthritis or osteomyelitis [<a href="#ref-4">4</a>, <a href="#ref-13">13</a>, <a href="#ref-18">18</a>]. The chronic form is often a sequel to inadequately treated acute cases.
Pathology
Gross Lesions
The hallmark gross lesions of acute fowl cholera include generalized congestion, petechial and ecchymotic hemorrhages on the heart (epicardium), serosal surfaces, and abdominal fat [<a href="#ref-4">4</a>]. Hepatomegaly with multifocal pale necrotic foci (miliary necrosis) is a consistent finding [<a href="#ref-4">4</a>, <a href="#ref-18">18</a>]. Splenomegaly, pulmonary edema, and fibrinous pericarditis are also commonly observed [<a href="#ref-4">4</a>, <a href="#ref-13">13</a>]. In the peracute form, lesions may be minimal or absent.
Histopathology
Histologically, acute cases exhibit a severe, multifocal necrotizing hepatitis and splenitis, with large numbers of Gram-negative coccobacilli visible within macrophages and extracellularly [<a href="#ref-4">4</a>]. Fibrinoid necrosis of blood vessels and thrombosis are common in the lung and liver. The chronic form is characterized by granulomatous inflammation with central caseous necrosis surrounded by epithelioid macrophages and multinucleated giant cells, particularly in the wattles, joints, and internal organs [<a href="#ref-4">4</a>].
Diagnostics
Definitive diagnosis of fowl cholera requires the isolation and identification of P. multocida from clinical specimens, supported by molecular and serological methods [<a href="#ref-18">18</a>, <a href="#ref-21">21</a>].
Traditional Diagnostic Methods
Direct Microscopy and Culture: Impression smears from liver, spleen, or bone marrow can be stained with Gram stain or methylene blue to reveal bipolar-staining coccobacilli [<a href="#ref-18">18</a>]. The organism is readily cultured on blood agar or MacConkey agar (with variable growth) under aerobic or microaerophilic conditions at 37°C for 18-24 hours [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>].
Biochemical Identification: P. multocida is oxidase-positive, catalase-positive, indole-positive, and is identified using commercial biochemical test panels [<a href="#ref-17">17</a>].
Molecular Diagnostics
Conventional and Real-Time PCR: Polymerase chain reaction (PCR) targeting the species-specific kmt1 gene is the gold standard for molecular confirmation [<a href="#ref-21">21</a>, <a href="#ref-22">22</a>]. Capsular typing is achieved using multiplex PCR targeting capsular biosynthesis genes (e.g., hyaD-hyaC for serogroup A) [<a href="#ref-10">10</a>].
Loop-Mediated Isothermal Amplification (LAMP): LAMP assays targeting the kmt1 gene offer a rapid, sensitive, and field-deployable alternative to PCR, with comparable diagnostic accuracy [<a href="#ref-21">21</a>].
Serological Assays
Enzyme-linked immunosorbent assays (ELISAs) are available for serological monitoring of antibody responses after vaccination or natural infection [<a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. In-house indirect ELISA kits using whole-cell antigens or recombinant proteins (e.g., lipoprotein E) have been developed and optimized for chickens [<a href="#ref-23">23</a>, <a href="#ref-25">25</a>].
Genomic and Molecular Epidemiology
Whole-genome sequencing (WGS) and draft genome analysis are increasingly used for high-resolution molecular epidemiology, antimicrobial resistance (AMR) profiling, and virulence gene characterization [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. Genome-wide association studies have identified the stringent response as a regulator of capsule production [<a href="#ref-12">12</a>]. Sequence typing (ST) based on multilocus sequence typing (MLST) reveals dominant clonal lineages, such as ST20 in Australian poultry [<a href="#ref-15">15</a>].
The following Mermaid diagram outlines a diagnostic decision tree for fowl cholera:
flowchart TD
A["Clinical Signs & History"] --> B{"Post-Mortem Examination"}
B --> C["Gross Lesions Consistent with FC"]
C --> D["Collect Samples: Liver, Spleen, Bone Marrow"]
D --> E["Gram Stain / Methylene Blue Stain"]
E --> F["Bipolar Coccobacilli?"]
F -->|"Yes"| G["Culture on Blood Agar"]
F -->|"No"| H["Consider Differential Diagnoses"]
G --> I["Colony Morphology & Biochemical Tests"]
I --> J["Species Confirmation: P. multocida"]
J --> K{"Advanced Testing"}
K --> L["PCR: kmt1 Gene"]
K --> M["Capsular Typing PCR"]
K --> N["Antimicrobial Susceptibility Test"]
K --> O["Whole-Genome Sequencing"]
L --> P["Confirm P. multocida"]
M --> Q["Serogroup A / D / F"]
N --> R["Resistance Profile"]
O --> S["Epidemiological Typing & AMR Genes"]
P --> T["Definitive Diagnosis"]Treatment
Antimicrobial Therapy
Therapeutic intervention relies on early administration of effective antimicrobials via feed or water [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-22">22</a>]. Commonly used drugs include tetracyclines (e.g., oxytetracycline, chlortetracycline), sulfonamides, penicillin, and fluoroquinolones [<a href="#ref-3">3</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-22">22</a>].
Antimicrobial Resistance (AMR)
Antimicrobial resistance is a growing global concern in P. multocida isolates from poultry [<a href="#ref-3">3</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-22">22</a>]. Resistance determinants have been identified against tetracyclines (tet genes), beta-lactams (bla genes), and sulfonamides (sul genes), often mediated by mobile genetic elements [<a href="#ref-3">3</a>, <a href="#ref-22">22</a>]. Multidrug-resistant (MDR) strains are increasingly reported, necessitating routine culture and susceptibility testing before treatment [<a href="#ref-18">18</a>, <a href="#ref-22">22</a>]. A study from Ethiopia found high levels of resistance to penicillin and tetracycline among isolates from chickens [<a href="#ref-18">18</a>]. In vitro studies have also explored alternative therapeutic agents, such as Egyptian artichoke extract, which demonstrated antibacterial activity against P. multocida [<a href="#ref-26">26</a>].
Supportive Care
Supportive measures include improving ventilation, reducing stocking density, correcting nutritional deficiencies, and ensuring clean water supply [<a href="#ref-19">19</a>].
Control and Prevention
Biosecurity
Strict biosecurity protocols are the cornerstone of fowl cholera prevention [<a href="#ref-14">14</a>, <a href="#ref-16">16</a>, <a href="#ref-19">19</a>]. These include all-in/all-out management, proper cleaning and disinfection of facilities, rodent and feral bird control, and quarantine of newly introduced birds [<a href="#ref-16">16</a>]. A mathematical compartmental model has demonstrated that a combination of biosecurity and culling of infected birds is the most effective control strategy in poultry farms [<a href="#ref-16">16</a>].
Vaccination
Vaccination is widely used to prevent fowl cholera, especially in high-risk areas and large commercial flocks [<a href="#ref-19">19</a>, <a href="#ref-24">24</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>, <a href="#ref-29">29</a>]. Several vaccine types are available:
- Bacterins (Inactivated Vaccines): Whole-cell killed bacterins provide serogroup-specific immunity and are commonly used [<a href="#ref-8">8</a>, <a href="#ref-24">24</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>]. Adjuvants, including hydrogel-based formulations and gamma-irradiated preparations, have been developed to enhance immunogenicity [<a href="#ref-24">24</a>, <a href="#ref-28">28</a>].
- Live Attenuated Vaccines: Attenuated strains, such as the serially passaged PMZ8 strain in ducks, offer broader cross-protection [<a href="#ref-30">30</a>]. The co-delivery of immune-modulating proteins has been shown to enhance live vaccine efficacy [<a href="#ref-29">29</a>].
- Recombinant and Subunit Vaccines: Next-generation vaccines include recombinant OMPs (e.g., OmpH, lipoprotein E) and flagellin-fusion proteins, which provide targeted immune responses and can be delivered via viral vectors [<a href="#ref-25">25</a>, <a href="#ref-27">27</a>, <a href="#ref-31">31</a>, <a href="#ref-32">32</a>, <a href="#ref-33">33</a>, <a href="#ref-34">34</a>, <a href="#ref-35">35</a>]. The use of NHEJ-CRISPR/Cas9 and Cre-LoxP systems to engineer recombinant turkey herpesvirus (HVT) expressing P. multocida OmpH has shown promise for fowl cholera prevention in ducks [<a href="#ref-31">31</a>]. Similarly, recombinant duck enteritis virus (DEV) vectors expressing OmpH have been constructed for simultaneous protection against duck viral enteritis and fowl cholera [<a href="#ref-33">33</a>, <a href="#ref-34">34</a>]. Subunit vaccines based on truncated LPS outer core are also under development [<a href="#ref-35">35</a>].
Eradication
Eradication is difficult due to the high prevalence of carrier birds. Depopulation of infected flocks followed by thorough cleaning and disinfection is recommended for severe outbreaks [<a href="#ref-19">19</a>].
Zoonotic Potential
The topic of "avian cholera transmission to humans" is clinically distinct from classical human cholera (caused by Vibrio cholerae). Pasteurella multocida is a well-recognized zoonotic pathogen in mammals, most commonly associated with bite wound infections in humans [<a href="#ref-20">20</a>]. Avian-to-human transmission is rare but documented. Most human cases involve direct contact with infected birds or contaminated environments, often through scratches or open wounds [<a href="#ref-20">20</a>]. Infections typically present as localized cellulitis, abscesses, or tenosynovitis. Systemic infections, including bacteremia and septicemia, occur predominantly in immunocompromised individuals [<a href="#ref-20">20</a>]. The organism is also carried in the oropharynx of healthy birds, so the risk primarily involves direct mucosal or percutaneous exposure. Standard hygiene precautions, including the use of personal protective equipment (gloves, masks) when handling sick or dead birds, are sufficient to mitigate the risk for veterinarians and poultry workers [<a href="#ref-20">20</a>].